• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2000年奥地利的疟疾情况

Malaria in Austria 1990-2000.

作者信息

Strauss R, Pfeifer C

机构信息

Federal Ministry for Social Security and Generations, Section Public Health, Vienna, Austria.

出版信息

Euro Surveill. 2003 Apr;8(4):91-6. doi: 10.2807/esm.08.04.00408-en.

DOI:10.2807/esm.08.04.00408-en
PMID:12764239
Abstract

In Austria, between 1990 and 2000, 924 travel related malaria cases were reported (mean = 84/year). No significant decreasing or increasing trends were observed. P. falciparum (n=517; 55.9%) accounted for the highest number of cases followed by P. vivax or ovale (n=321; 34.7%) and P. malariae (n=29; 2.2%). Most infections were contracted in highly endemic malaria regions (n=686; 74.2%) and most cases were reported from the largest counties: Vienna (n=336, 36.4%), Styria (n=156, 16.8%), and Lower Austria (n=151, 16.3%). Overall, 12 deaths occurred, most were caused by P. falciparum (n=9, 75%; case fatality rate: 1.9%). Data on chemoprophylaxis was available for 752 cases (81.4%) but only half of them (n=367, 48.8%) gave detailed information on the drug used. Data on compliance were obtained for only 45.4% of the cases, with only about 60% of patients completing the full course of prophylaxis.

摘要

在奥地利,1990年至2000年期间,共报告了924例与旅行相关的疟疾病例(平均每年84例)。未观察到明显的上升或下降趋势。恶性疟原虫(n = 517;55.9%)导致的病例数最多,其次是间日疟原虫或卵形疟原虫(n = 321;34.7%)和三日疟原虫(n = 29;2.2%)。大多数感染发生在疟疾高度流行地区(n = 686;74.2%),大多数病例来自最大的几个县:维也纳(n = 336,36.4%)、施蒂利亚州(n = 156,16.8%)和下奥地利州(n = 151,16.3%)。总体而言,有12人死亡,大多数由恶性疟原虫引起(n = 9,75%;病死率:1.9%)。752例病例(81.4%)有化学预防的数据,但其中只有一半(n = 367,48.8%)提供了所使用药物的详细信息。仅45.4%的病例获得了依从性数据,只有约60%的患者完成了全程预防用药。

相似文献

1
Malaria in Austria 1990-2000.1990 - 2000年奥地利的疟疾情况
Euro Surveill. 2003 Apr;8(4):91-6. doi: 10.2807/esm.08.04.00408-en.
2
[The proper use of antimalarial drugs currently available].[当前可用抗疟药物的合理使用]
Bull Soc Pathol Exot. 1998;91(5 Pt 1-2):493-6.
3
In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.来自印度尼西亚伊里安查亚省西北部偏远的加格岛的恶性疟原虫和间日疟原虫对抗疟药的体内反应。
Am J Trop Med Hyg. 1999 Apr;60(4):542-6. doi: 10.4269/ajtmh.1999.60.542.
4
Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.英国旅行者疟疾化学预防模型的比较获益。
Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt B):726-32. doi: 10.1016/j.tmaid.2014.08.005.
5
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.在巴布亚新几内亚,阿莫地喹或氯喹联合磺胺多辛-乙胺嘧啶治疗恶性疟原虫和间日疟原虫疟疾的疗效较低。
Am J Trop Med Hyg. 2007 Nov;77(5):947-54.
6
Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.甲氟喹、氯喹加乙胺嘧啶-磺胺多辛(Fansidar)和氯喹在泰国东部作为疟疾预防药物的比较。
Southeast Asian J Trop Med Public Health. 1991 Jun;22(2):183-9.
7
Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study.与高负担贫血相关的三日疟原虫感染:一项基于医院的监测研究
PLoS Negl Trop Dis. 2015 Dec 31;9(12):e0004195. doi: 10.1371/journal.pntd.0004195. eCollection 2015 Dec.
8
The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia.印度尼西亚北苏门答腊尼亚斯岛人类疟疾的药物敏感性及传播动态
Ann Trop Med Parasitol. 2002 Jul;96(5):447-62. doi: 10.1179/000349802125001249.
9
Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.巴布亚新几内亚针对恶性疟原虫、间日疟原虫和三日疟原虫的标准治疗方案的寄生虫学及临床疗效
P N G Med J. 2005 Sep-Dec;48(3-4):141-50.
10
High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.埃塞俄比亚南部恶性疟原虫和间日疟原虫耐药性突变的高流行率。
Malar J. 2006 Jul 3;5:54. doi: 10.1186/1475-2875-5-54.

引用本文的文献

1
Evidence of malarial chemoprophylaxis among travellers who died from malaria: a systematic review and meta-analysis.旅行者死于疟疾的抗疟化学预防证据:系统评价和荟萃分析。
Malar J. 2023 Nov 25;22(1):359. doi: 10.1186/s12936-023-04794-x.
2
Malaria in Austria : A retrospective analysis of malaria cases diagnosed at a reference center in 2010-2020.奥地利的疟疾:2010-2020 年在参考中心诊断的疟疾病例回顾性分析。
Wien Klin Wochenschr. 2023 Nov;135(21-22):617-624. doi: 10.1007/s00508-023-02179-3. Epub 2023 Apr 17.
3
Epidemiology and clinical features of imported malaria: a 14-year retrospective single-centre descriptive study in Prague, Czech Republic.
流行病学和输入性疟疾的临床特征:捷克布拉格 14 年回顾性单中心描述性研究。
Malar J. 2022 Sep 6;21(1):257. doi: 10.1186/s12936-022-04282-8.
4
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop.输入欧洲的间日疟流行病学及临床特征:来自TropNetEurop的哨点监测数据
Malar J. 2004 Mar 8;3:5. doi: 10.1186/1475-2875-3-5.